Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TSM | buy-back tender | 05/08/22 | 58 | 16K | |||
|
|||||||
TSM | Is there any benefit holding the AU shares? | 26/02/19 | 0 | 551 | |||
|
|||||||
TSM | Ann: Becoming a substantial holder | 09/12/16 | 3 | 2.3K | |||
|
|||||||
TSM | Ann: Removal from Offical List | 05/12/16 | 0 | 815 | |||
|
|||||||
TSM | Ann: Suspension from Official Quotation | 20:24 | 0 | 762 | |||
|
|||||||
TSM | Ann: Admission to Trading on AIM and First Day of Dealings | 19:54 | 0 | 692 | |||
|
|||||||
TSM | Ann: Update of Delisting Process | 10:06 | 0 | 758 | |||
|
|||||||
TSM | Ann: Results of Meeting | 30/11/16 | 0 | 557 | |||
|
See All Discussions